Australian Infant Communication and Engagement Study (AICES)
The Australian Infant Communication and Engagement Study (AICES) is a multisite (Perth, Melbourne), randomized clinical trial that is being conducted in partnership with Telethon Kids Institute, Western Australia Child Development Service, Latrobe University and the University of Manchester.
The aim of this study is to understand how to best support early social and communication development in infants showing early delays.
We are trialling a new, parent-mediated, video-aided feedback therapy called VIPP. This therapy aims to optimise social and communication development in infants aged 9-14 months by helping parents understand and adapt to their infant's communication style. The therapy involves 10 sessions over a 5-month period. The VIPP intervention will be compared to current, best practice protocols in the community for infants with social and communication delays. We are working with child health services to identify infants that may benefit from early intervention. Infants enrolled in the study will complete several assessments with our research team over a two year period so that we can see how they are improving and developing up until they are around three years of age.
Who can participate?
Infants aged 9-14 months who have been referred to the study through the Child Development Service.
Who is running the study?
The AICES study is led by Prof Andrew Whitehouse (Telethon Kids Institute/UWA), Kristelle Hudry (LaTrobe University), John Wray (WA Child Development Service) and Jonathan Green (University of Manchester). Other investigators on the project are Josephine Barbaro, Cheryl Dissanayake, Teresa Lacono, Lacey Chetcuti, Stefanie Dimov, Megan Grant, Scott Wakeling, Kim Howland, Leonie Segal, Emma Davidson, Jane Doyle, Michelle Renton, Cat Rowbottam, Vicky Slonims, Carol Taylor, Ming Mai Wan, Matthew Cooper, Murray Maybery, Kandice Varcin, Maryam Boutrus, Alena Dass and Gail Alvares.
How can I get involved?
Please contact Study Coordinator Kandice Varcin via email or on (08) 6319 1702